Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali(Fondazione IRCCS Istituto Nazionale dei Tumori), Ofer Merimsky(Tel Aviv Sourasky Medical Center), Laurence Brugières(Institut Gustave Roussy), Paul C. Jutte(University Medical Center Groningen), N. Abecassis, Ruth Ladenstein(St Anna Children's Hospital), Thomas Brodowicz(Vienna General Hospital), Suzanne E. J. Kaal(Radboud University Nijmegen), Angelo Paolo Dei Tos(University of Padua), Hannu T. Aro(University of Turku), Hans Gelderblom(Leiden University Medical Center), R. Biagini(Tumori Foundation), Stefan Bielack(Olgahospital), Catharina Dhooge(Ghent University Hospital), Sebastian Bauer(Science for Life Laboratory), Virginia Ferraresi(Cancer Institute (WIA)), Kateřina Kopečková(University Hospital in Motol), Rick L. Haas(Leiden University Medical Center), Mikael Eriksson(Herlev Hospital), A. Bassim Hassan(Kassala University), Iwona Ługowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Peter Hohenberger(University of Mannheim), Dagmar Adámková Krákorová(Masaryk Memorial Cancer Institute), Robin L. Jones(Institute of Cancer Research), Giovanni Grignani(Candiolo Cancer Institute), Anna Maria Frezza(University of Milan), Ian Judson(Erasmus Hospital), Palma Dileo(University College Hospital), Xavier García del Muro(Institut Català d'Oncologia), Sylvie Bonvalot(Dana-Farber Cancer Institute), Angela Buonadonna(Centro di Riferimento Oncologico), Nathalie Gaspar(Université Paris-Sud), Bernadette Brennan(Royal Manchester Children's Hospital), Stefanie Hecker‐Nolting(University College London Hospitals NHS Foundation Trust), Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Rolf D. Issels(LMU Klinikum), Franca Fagioli(Ospedale Regina Margherita), Bernd Kasper(Heidelberg University), I. Boukovinas, Judith V.M.G. Bovée(Leiden University Medical Center), Heikki Joensuu(Orion Corporation (Finland)), Andrea Ferrari(University of Milan), Stefano Ferrari(University of Bergamo), Thierry Gil(Institut Jules Bordet), Alexander N. Fedenko(Russian Cancer Research Center NN Blokhin), Leo Kager(University of Vienna), Silvia Gasperoni(Azienda Ospedaliero-Universitaria Careggi), Axel Le Cesne(Institut Gustave Roussy)
Cited by 641
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k